Inhaled Nitric Oxide (iNO)
Customize your policy alerts
Sign up for all healthplanofupperohiovalley policy alerts
Know when healthplanofupperohiovalley releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs medical-necessity coverage and coding for inhaled nitric oxide (iNO) therapy services. It applies to providers and facilities serving the plan's Commercial, Mountain Health Trust, PEIA, and Self-Funded lines of business.
The policy added medical-necessity criteria for using iNO to assess pulmonary vasoreactivity in individuals with pulmonary hypertension.
The policy added traumatic brain injury to the list of iNO indications considered not medically necessary and non-covered.
The policy added peer-reviewed-literature language to the statement that iNO therapy outside the listed criteria is experimental or investigational.
The policy added a purpose section, definitions, diagnosis codes, and updated references and formatting.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.